Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Beta-carotene

This article was originally published in The Tan Sheet

Executive Summary

Beta-carotene: Physicians' Health Survey study shows no increase in T-cell mediated immunity among subjects taking 50 mg of BASF Lurotin on alternate days for a period of 12 years, according to a report by Michelle Santos et al. in the October issue of the American Journal of Clinical Nutrition. The long-term PHS study of 22,071 physicians nationwide has been examining research on chemoprevention using both aspirin and beta-carotene ("The Tan Sheet" June 2, In Brief). In the Santos et al. study, a 12-year, randomized, double-blind, placebo-controlled trial ending in 1995 among 73 physicians in the Boston area, found no significant decrease in prostaglandin E2 production among subjects who took the beta-carotene supplement...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087631

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel